The cyclin dependent kinase inhibitor p21Cip1/Waf1 is a therapeutic target in high-risk neuroblastoma

Overview of attention for article published in Frontiers in oncology, September 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 6,542 followers.

📣 Original Research: The cyclin dependent kinase inhibitor p21Cip1/Waf1 is a therapeutic target in high-risk #neuroblastoma 👨‍⚕️👩‍⚕️ Sorteberg AL et al Read here 👉 https://t.co/vj99Dm3Pw7 #Drugtargets

15 Sep 2022

Reply Repost Favourite

New research: The cyclin dependent kinase inhibitor p21Cip1/Waf1 is a therapeutic target in high-risk neuroblastoma: Platinum-based chemotherapies such as cisplatin are used as first-line treatment for the paediatric tumour neuroblastoma.… https://t.co/LuU

07 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.